No Data
Penney Testing: Penney Testing Group Co., Ltd. 2024 Third Quarter Report (Updated)
Penney Testing: Penney Testing Group Co., Ltd. 2024 Third Quarter Report Correction Notice
Express News | Puni Biomedical obtained national GLP certification.
Express News | Funey Test: The wholly-owned subsidiary passed the GLP inspection and obtained the "Drug GLP Certification Certificate".
Puny test (300887): 3Q performance meets expectations, waiting for adjustment to unleash growth potential.
3Q24 performance meets our expectations. The company announced 1~3Q24 performance: revenue of 1.123 billion yuan, -36.1% year-on-year; net income attributable to the parent company of -0.234 billion yuan, -322.2% year-on-year. For Q3 24 performance: revenue
Punic Testing (300887): The profit is still in deficit, looking forward to the effects of transformation and adjustment.
Pooni test released its third quarter report for 2024, with revenue of 1.123 billion yuan in the first three quarters, a year-on-year decrease of 36.1%; net income attributable to shareholders was -0.234 billion yuan, compared to a profit of 0.105 billion yuan in the same period last year; 2024.
No Data
No Data